Non-pharmaceutical Motion Sickness Mitigation

Mayo Clinic

Status: Completed

Conditions: Healthy

Treatments: Device: Galvanic Vestibular Stimulation

Study type: Interventional

Funder types: Other

Identifiers

NCT04859868

80NSSC21K0175 (Other Grant/Funding Number)

20-005763

Details and patient eligibility

About

The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.

Enrollment: 29 patients

Sex: All

Ages: 21 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be able to consent to participate themselves.
• Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
• No racial ethnic groups will be excluded.
• Must be fluent speakers of English.

Exclusion criteria

• History of vestibular disease, migraine, or significant balance disorder.
• Traumatic brain injury.
• Recent middle ear infection or recent motion sickness (within 72 hours).
• History of severe motion sensitivity.
• Women who are pregnant.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

29 participants in 3 patient groups

Galvanic Vestibular Stimulation During the Entire Session

Experimental group

Description:

Subjects given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation ON from beginning.

Treatment:

Device: Galvanic Vestibular Stimulation

No Galvanic Vestibular Stimulation

No Intervention group

Description:

Subjects were not given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation entire session.

Galvanic Vestibular Stimulation Starting From Mid-session

Experimental group

Description:

Subjects given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation ON from the middle of the session.

Treatment:

Device: Galvanic Vestibular Stimulation